Home  »  Business   »  Eli Lilly and Company (NYSE:LLY) Lost -4.24% In A ...

Eli Lilly and Company (NYSE:LLY) Lost -4.24% In A Week: What’s Driving The Stock?

In recent trading session, Eli Lilly and Company (NYSE:LLY) saw 2.01 million shares changing hands at last check today with its beta currently measuring 0.37. Company’s recent per share price level of $307.93 trading at $11.45 or 3.86% at last check today assigns it a market valuation of $282.24B. That most recent trading price of LLY’s stock is at a discount of -8.9% from its 52-week high price of $335.33 and is indicating a premium of 28.49% from its 52-week low price of $220.20. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.4 million shares which gives us an average trading volume of 2.56 million if we extend that period to 3-months.

For Eli Lilly and Company (LLY), analysts’ consensus is at an average recommendation of an Overweight while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 22 analysts covering the stock, 0 rated the stock as a Sell while 2 recommended an Overweight rating for the stock. 6 suggested the stock as a Hold whereas 13 see the stock as a Buy. 1 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of $1.95 in the current quarter.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.

Sponsored

Eli Lilly and Company (NYSE:LLY) trade information

Upright in the green today for gaining 3.86%, in the last five days LLY remained trading in the red while hitting it’s week-highest on Friday, 09/16/22 when the stock touched $307.93 price level, adding 1.29% to its value on the day. Eli Lilly and Company’s shares saw a change of 7.33% in year-to-date performance and have moved -4.24% in past 5-day. Eli Lilly and Company (NYSE:LLY) showed a performance of -8.24% in past 30-days. Number of shares sold short was 5.46 million shares which calculate 1.86 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $341.10 to the stock, which implies a rise of 9.72% to its recent value today. Analysts have been projecting $202.00 as a low price target for the stock while placing it at a high target of $412.00. It follows that stock’s current price would drop -33.8% in reaching the projected high whereas dropping to the targeted low would mean a gain of 34.4% for stock’s current value.

Eli Lilly and Company (LLY) estimates and forecasts

Statistics highlight that Eli Lilly and Company is scoring comparatively lower than the scores of other players of the relevant industry. The company added 4.02% of value to its shares in past 6 months, showing an annual growth rate of -2.33% while that of industry is 10.00. Apart from that, the company came lowering its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to increase by 14.00% in the current quarter and calculating -4.90% decrease in the next quarter. This year revenue growth is estimated to rise 13.00% from the last financial year’s standing.

5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $6.97 billion for the same. And 4 analysts are in estimates of company making revenue of $7.67 billion in the next quarter that will end on Dec 2022. Company posted $5.9 billion and $7.24 billion of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 18.20% while estimating it to be 6.00% for the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 18.90% during past 5 years. In 2022, company’s earnings growth rate is likely to be around -9.80% while estimates for its earnings growth in next 5 years are of 17.54%.

LLY Dividends

Eli Lilly and Company is more likely to be releasing its next quarterly report between April 25 and April 29 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

Eli Lilly and Company (NYSE:LLY)’s Major holders

Insiders are in possession of 0.20% of company’s total shares while institution are holding 84.06 percent of that, with stock having share float percentage of 84.23%. Investors also watch the number of corporate investors in a company very closely, which is 84.06% institutions for Eli Lilly and Company that are currently holding shares of the company. Lilly Endowment, Inc is the top institutional holder at LLY for having 104.16 million shares of worth $33.77 billion. And as of Jun 29, 2022, it was holding 10.96% of the company’s outstanding shares.

The second largest institutional holder is Vanguard Group, Inc. (The), which was holding about 70.48 million shares on Mar 30, 2022. The number of shares represents firm’s hold over 7.42% of outstanding shares, having a total worth of $20.18 billion.

On the other hand, Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 30, 2022, the former fund manager was holding 24.74 million shares of worth $7.09 billion or 2.60% of the total outstanding shares. The later fund manager was in possession of 17.38 million shares on Mar 30, 2022, making its stake of worth around $4.98 billion in the company or a holder of 1.83% of company’s stock.

Leave a Comment

Your email address will not be published.

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]